High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer
High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer
Enrollment in high-deductible health plans (HDHPs) is associated with delays in the diagnosis of metastatic cancer, according to research presented at the 2022 ASCO Annual Meeting.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->